Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Position in GILD — Gilead Sciences, Inc.
CIK 2032331
SINGAPORE, U0
Position in GILD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,667,004
-$716,484 QoQ
Shares Held
11,961
-38.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2025CallValue
$425,790
CallShares
3,800
PutValue
$425,790
PutShares
3,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds $7,535,126 across 3 Drug Manufacturers - General names.
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,667,004 | 11,961 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,383,488 | 19,419 | Shares | Defined | 2026-02-11 | |
| 2025-03-31 | $425,790 | 3,800 | Call | Defined | 2025-05-13 | |
| 2025-03-31 | $425,790 | 3,800 | Put | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||